Literature DB >> 7572073

Acquired hepatocerebral degeneration in a liver transplant recipient.

D Soffer1, Y Sherman, R Tur-Kaspa, A Eid.   

Abstract

A 47-year-old-man lapsed into coma 12 h after liver transplantation, and remained comatose until death 38 days later. Prior to transplantation he had repeated episodes of hepatic encephalopathy, but no fixed neurological signs. Autopsy revealed typical features of acquired hepatocerebral degeneration with diffuse but patchy pseudolaminar cortical necrosis, variable amount of neuronal loss in the cerebral cortex, basal ganglia and other areas, and proliferation of Alzheimer type II glia. In addition, there was central pontine and extensive extrapontine myelinolysis involving the lateral and medical geniculate bodies, the thalamus, internal capsule, fornix, mamillothalamic tract, white matter bundles in the caudate and pallidum, the oculomotor nuclei and the foliar white matter of the cerebellum. The distinction between myelinolytic lesions and lesions due to hepatocerebral degeneration was not always clear. Although neurological complications and brain lesions are rather common after liver transplantation, there have been no reports of acquired hepatocerebral degeneration in liver transplant recipients. Our data lend support to the idea that a single prolonged comatose episode, due to hepatic dysfunction, may induce permanent parenchymal brain damage.

Entities:  

Mesh:

Year:  1995        PMID: 7572073     DOI: 10.1007/BF00294467

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  15 in total

1.  Pontine and extrapontine myelinolysis.

Authors:  D G Wright; R Laureno; M Victor
Journal:  Brain       Date:  1979-06       Impact factor: 13.501

Review 2.  Neurologic complications of liver transplantation.

Authors:  A J Martinez; C Estol; A A Faris
Journal:  Neurol Clin       Date:  1988-05       Impact factor: 3.806

3.  Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.

Authors:  Z K Wszolek; R D McComb; R F Pfeiffer; R E Steg; R P Wood; B W Shaw; R S Markin
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

4.  Distribution of cerebral lesions in acquired hepatocerebral degeneration.

Authors:  M H Finlayson; B Superville
Journal:  Brain       Date:  1981-03       Impact factor: 13.501

5.  Neurological complications following liver transplantation.

Authors:  D H Adams; S Ponsford; B Gunson; A Boon; L Honigsberger; A Williams; J Buckels; E Elias; P McMaster
Journal:  Lancet       Date:  1987-04-25       Impact factor: 79.321

Review 6.  Central nervous system lesions in adult liver transplant recipients: clinical review with implications for management.

Authors:  N Singh; V L Yu; T Gayowski
Journal:  Medicine (Baltimore)       Date:  1994-03       Impact factor: 1.889

7.  Neurologic complications of liver transplantation.

Authors:  D P Vogt; R J Lederman; W D Carey; T A Broughan
Journal:  Transplantation       Date:  1988-06       Impact factor: 4.939

Review 8.  Neuropathologic findings after liver transplantation.

Authors:  J A Ferreiro; M A Robert; J Townsend; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

9.  Central pontine myelinolysis after liver transplantation.

Authors:  C J Estol; A A Faris; A J Martinez; M Ahdab-Barmada
Journal:  Neurology       Date:  1989-04       Impact factor: 9.910

10.  Distribution of demyelinating lesions in pontine and extrapontine myelinolysis--three autopsy cases including one case devoid of central pontine myelinolysis.

Authors:  R Okeda; M Kitano; M Sawabe; I Yamada; M Yamada
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

View more
  7 in total

Review 1.  Neuronal cell death in hepatic encephalopathy.

Authors:  Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2007-12       Impact factor: 3.584

Review 2.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 3.  Metal toxicity, liver disease and neurodegeneration.

Authors:  Roger F Butterworth
Journal:  Neurotox Res       Date:  2010-04-06       Impact factor: 3.911

Review 4.  Acquired hepatocerebral degeneration: a case report.

Authors:  Wei-Xing Chen; Ping Wang; Sen-Xiang Yan; You-Ming Li; Chao-Hui Yu; Ling-Ling Jiang
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

5.  Cerebellar neurodegeneration in a new rat model of episodic hepatic encephalopathy.

Authors:  Teresa García-Lezana; Marc Oria; Jordi Romero-Giménez; Jordi Bové; Miquel Vila; Joan Genescà; Laia Chavarria; Juan Cordoba
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-20       Impact factor: 6.200

6.  Thalamic Structural Connectivity Abnormalities in Minimal Hepatic Encephalopathy.

Authors:  Hua-Jun Chen; Xiao-Hong Zhang; Jia-Yan Shi; Shao-Fan Jiang; Yi-Fan Sun; Ling Zhang; Dan Li; Rong Chen
Journal:  Front Neuroanat       Date:  2021-02-25       Impact factor: 3.856

7.  Spastic paraparesis associated with advanced liver cirrhosis: a condition obscure in terms of treatment and prognosis.

Authors:  Jaspreet Kaur; Gautam Jesrani; Monica Gupta; Sarabmeet Singh Lehl
Journal:  BMJ Case Rep       Date:  2020-06-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.